New options for the management of hyperparathyroidism after renal transplantation
Open Access
- 1 January 2012
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Transplantation
- Vol. 2 (3), 41-45
- https://doi.org/10.5500/wjt.v2.i3.41
Abstract
The persistence and severity of hyperparathyroidism (HPT) post-renal transplantation is relatively frequent and primarily associated with the timing and its magnitude in the pre-transplant period and with the presence of parathyroid adenomas. HPT after renal transplantation is clinically manifested with hypercalcemia, hypophosphatemia, bone pain, fractures, and in more serious cases with cardiovascular calcifications that affect the survival. The primary clinical objective for patients with secondary HPT after renal transplantation is to obtain a level of parathyroid hormone (PTH) adequate to the renal transplanted function and to normalize levels of calcium, phosphorus and vitamin D. In many cases during this period, the development of hypercalcemia and/or hypophosphatemia makes it necessary to take different therapeutic measures. The use of vitamin D or its analogues has been extrapolated from the management of pre-transplant HPT obtaining variable outcomes, although its use is limited by its capacity to produce hypercalcemia. Calcimimetics are drugs that have proven be effective in reducing PTH levels in patients with HPT on dialysis and has been effective in reducing up to 50% PTH levels in moderate to severe HPT in post-renal transplantation.When HPT persists after renal transplantation and does not respond to medical treatment, invasive management by percutaneous ethanol injection therapy of parathyroid glands or parathyroidectomy should be considered. The emergence of new methods for the management of HPT expands the availability of therapeutic tools for transplant patients.Keywords
This publication has 34 references indexed in Scilit:
- Use of Percutaneous Ethanol Injection Therapy for Recurrent Secondary Hyperparathyroidism after Subtotal ParathyroidectomyInternational Journal of Nephrology, 2011
- Chapter 5: Evaluation and treatment of kidney transplant bone diseaseKidney International, 2009
- Effects of vitamin D supplementation on the calcium–phosphate balance in renal transplant patientsKidney International, 2009
- Percutaneous ethanol injection therapy in post-transplant patients with secondary hyperparathyroidismTransplant International, 2007
- Parathyroidectomy after successful kidney transplantation: a single centre studyNephrology Dialysis Transplantation, 2007
- Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS)American Journal of Kidney Diseases, 2004
- Treatment with intermittent calcitriol and calcium reduces bone loss after renal transplantationKidney International, 2004
- Treatment of refractory secondary hyperparathyroidism with ethanol injection: The importance of glandular volumeKidney International, 2003
- Association of decreased calcium-sensing receptor expression with proliferation of parathyroid cells in secondary hyperparathyroidismKidney International, 2000
- Different Patterns of Renal Osteodystrophy in IberoamericaThe American Journal of the Medical Sciences, 2000